Patents by Inventor Oleh Taratula

Oleh Taratula has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230338575
    Abstract: Disclosed herein are embodiments of a nanoparticle suitable for use in providing hyperthermia treatment. The nanoparticle may be a cobalt-doped iron oxide nanoparticle. Also disclosed are compositions comprising the nanoparticle. The composition may further comprise a polymer and/or a targeting moiety. Further disclosed and methods for making the nanoparticle and the composition, and embodiments of a method for using the nanoparticle or a composition thereof. The nanoparticle may be useful for treating cancer, and/or endometriosis.
    Type: Application
    Filed: March 20, 2023
    Publication date: October 26, 2023
    Applicants: Oregon State University, Oregon Health & Science Univesity
    Inventors: Olena Taratula, Oleh Taratula, Ananiya A. Demessie, Ov Slayden, Youngrong Park
  • Patent number: 10905766
    Abstract: mRNA polymer complexes and drug delivery systems are disclosed herein that include a cationic polymer electrostatically complexed to an mRNA molecule that encodes a desired protein. Also disclosed herein are methods of treating as well as methods of slowing the loss of, increasing, and/or maintaining lean muscle mass in a subject, such as using mRNA polymer complexes and drug delivery systems.
    Type: Grant
    Filed: May 18, 2018
    Date of Patent: February 2, 2021
    Assignee: Oregon State University
    Inventors: Oleh Taratula, Canan Schumann, Olena Taratula, Adam W. G. Alani
  • Patent number: 10646472
    Abstract: Embodiments of a composition comprising a photosensitive compound and a polymer nanoparticle are disclosed herein. The composition may further comprise a targeting moiety. In some embodiments, the photosensitive compound is a phthalocyanine or phthalocyanine derivative, such as a naphthalocyanine. Upon irradiation with near infrared light, the composition may be used as a fluorescent imaging agent and/or as a phototherapeutic agent, such as for photodynamic and/or photothermal therapies. In certain embodiments, the composition is used to treat certain cancers.
    Type: Grant
    Filed: October 17, 2017
    Date of Patent: May 12, 2020
    Assignee: Oregon State University
    Inventors: Olena Taratula, Oleh Taratula, Adam Alani
  • Publication number: 20180303944
    Abstract: mRNA polymer complexes and drug delivery systems are disclosed herein that include a cationic polymer electrostatically complexed to an mRNA molecule that encodes a desired protein. Also disclosed herein are methods of treating as well as methods of slowing the loss of, increasing, and/or maintaining lean muscle mass in a subject, such as using mRNA polymer complexes and drug delivery systems.
    Type: Application
    Filed: May 18, 2018
    Publication date: October 25, 2018
    Applicant: Oregon State University
    Inventors: Oleh Taratula, Canan Schumann, Olena Taratula, Adam W.G. Alani
  • Publication number: 20180028496
    Abstract: Embodiments of a composition comprising a photosensitive compound and a polymer nanoparticle are disclosed herein. The composition may further comprise a targeting moiety. In some embodiments, the photosensitive compound is a phthalocyanine or phthalocyanine derivative, such as a naphthalocyanine. Upon irradiation with near infrared light, the composition may be used as a fluorescent imaging agent and/or as a phototherapeutic agent, such as for photodynamic and/or photothermal therapies. In certain embodiments, the composition is used to treat certain cancers.
    Type: Application
    Filed: October 17, 2017
    Publication date: February 1, 2018
    Applicant: Oregon State University
    Inventors: Olena Taratula, Oleh Taratula, Adam Alani
  • Patent number: 9289505
    Abstract: The present invention provides compositions and methods for the delivery of nucleic acids to a cell. The present invention additionally provides compositions and methods for the treatment of a disease or disorder, particularly cancer. In a particular embodiment, the composition comprises at least one pharmaceutically acceptable carrier and at least one liposome or dendrimer comprising at least two chemotherapeutic agents with different mechanisms of action and at least two inhibitors of cellular drug resistance.
    Type: Grant
    Filed: August 17, 2011
    Date of Patent: March 22, 2016
    Assignee: Rutgers, The State University of New Jersey
    Inventors: Tamara Minko, Lorna Rodriguez-Rodriguez, Olga B. Garbuzenko, Oleh Taratula, Vatsal Shah
  • Publication number: 20130302257
    Abstract: The present invention provides compositions and methods for the delivery of nucleic acids to a cell. The present invention additionally provides compositions and methods for the treatment of a disease or disorder, particularly cancer.
    Type: Application
    Filed: August 17, 2011
    Publication date: November 14, 2013
    Applicants: UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY, RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
    Inventors: Tamara Minko, Lorna Rodriguez-Rodriguez, Olga B. Garbuzenko, Oleh Taratula, Vatsal Shah